Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Activation of group-I metabotropic glutamate receptors, mGlu1 and mGlu5, triggers a variety of signalling pathways in neurons and glial cells, which are differently implicated in synaptic plasticity. The earliest and much of key studies discovered abnormal mGlu5 receptor function in Fragile X syndrome (FXS) mouse models which then motivated more recent work that finds mGlu5 receptor dysfunction in related disorders such as intellectual disability (ID), obsessive-compulsive disorder (OCD) and autism. Therefore, mGlu1/5 receptor dysfunction may represent a common aetiology of these complex diseases. Furthermore, many studies have focused on dysregulation of mGlu5 signalling to synaptic protein synthesis. However, emerging evidence finds abnormal mGlu5 receptor interactions with its scaffolding proteins in FXS which results in mGlu5 receptor dysfunction and phenotypes independent of signalling to protein synthesis. Finally, both an increased and reduced mGlu5 functioning seem to be associated with ID and autism spectrum disorders, with important consequences for potential treatment of these developmental disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · cited 12×
“Thus, disruption of mGlu5-Homer interaction is not involved in the abnormal translational control of FMRP target mRNAs.”
BackgroundInfluentialAdvances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866 · cited 1×
“Local translation of synaptic mRNAs FXS is the most common inherited form of ID and a leading genetic cause of autism (Abrahams and Geschwind, 2008; Kelleher and Bear, 2008).”
BackgroundBoosting slow oscillations during sleep potentiates memory
Marshall, L., Helgadóttir, H., Mölle, M., & Born, J. (2006) · Nature · doi:10.1038/nature05278 · Cited by 1,792
Coordinated memory replay in the visual cortex and hippocampus during sleep
Ji, D., & Wilson, M. A. (2007) · Nature Neuroscience · doi:10.1038/nn1825 · Cited by 1,669 · cited 1×
“When UP states occur spontaneously and repeatedly, they underlie the neocortical “slow oscillation” (<1 Hz) during slow wave sleep and may be involved in long-term memory consolidation (Crunelli and Hughes, 2010; Ji and Wilson, 2007; Marshall and Born, 2007; Marshall et al., 2006).”
BackgroundEndogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607 · cited 1×
“CB1 receptors are abundantly expressed on pre-synaptic terminals of GABAergic/Cholecystokinin positive interneurons (Katona et al., 1999; Wilson and Nicoll, 2001).”
BackgroundDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602 · cited 2×
“Interestingly, defects in mGlu5 receptor-dependent ERK1/2 phosphorylation were not rescued by overexpression of two Shank3 carrying mutations that have been found in patients with autism (Durand et al., 2007), suggesting that alteration of mGlu5 receptor signalling might be a common mechanism in Phelan Mc Dermid disea…”
BackgroundShank3 mutant mice display autistic-like behaviours and striatal dysfunction
Peça, J., Feliciano, C., Ting, J. T., Wang, W., Wells, M. F., Venkatraman, T. N., Lascola, C. D., Fu, Z., & Feng, G. (2011) · Nature · doi:10.1038/nature09965 · Cited by 1,570 · cited 2×
“However, in Shank 1 and Shank 3 mutant mice a reduction of Homer1 proteins might implicate an alteration of mGlu5-mediated signalling in these mutant mice (Hung et al., 2008; Peça et al., 2011; Wang et al., 2011), whereas only NMDA receptor mediated signalling appear to be impaired in Shank 2 mutant mice (Won et al.”
BackgroundAltered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 4×
“…and non syndromic autism The first studies aimed at investigating the expression of mGlu5 receptor in the brain of Fragile X mouse models revealed no changes in levels of protein expression in hippocampal homogenates (Huber et al., 2002) and forebrain synaptosomes (Giuffrida et al., 2005).”
BackgroundResultSelf-citationThe TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237 · cited 1×
“These two proteins behave as GAPs (GTPase-activating proteins) of the small GTP-binding protein, Rheb (Ras homologue enriched in brain), thereby restraining the activation of mTORC1 (mammalian target of rapamycin complex 1) (Huang and Manning, 2008).”
BackgroundKatona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218 · cited 1×
“CB1 receptors are abundantly expressed on pre-synaptic terminals of GABAergic/Cholecystokinin positive interneurons (Katona et al., 1999; Wilson and Nicoll, 2001).”
Background
Cited by
Synaptopathies: synaptic dysfunction in neurological disorders – A review from students to students
Lepeta, K., Lourenco, M. V., Schweitzer, B. C., Martino Adami, P. V., Banerjee, P., Catuara‐Solarz, S., de La Fuente Revenga, M., Guillem, A. M., Haidar, M., Ijomone, O. M., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13713 · Cited by 386
Rossignol, D. A., & Frye, R. E. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00087 · Cited by 79
Oxytocin: Parallel Processing in the Social Brain?
Dölen, G. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12284 · Cited by 65
López-Merino, E., Cuartero, M. I., Esteban, J. A., & Briz, V. (2023) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09697-2 · Cited by 44
“Particularly, synaptic plasticity events such as long-term potentiation (LTP) and long-term depression (LTD) are typically affected in genetic animal models of ASD and intellectual disability (D’Antoni et al. 2014; Knafo and Este-ban 2017).”
Background
Metadata
- Authors
- D’Antoni, S., Spatuzza, M., Bonaccorso, C. M., Musumeci, S. A., Ciranna, L., Nicoletti, F., Huber, K. M., & Catania, M. V.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 46
- Pages
- 228-241
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2022138812
- Cited by
- 96
- References
- 70
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism. https://app.cochat.ai/papers/10.1016/j.neubiorev.2014.02.003
- The paper
- D’Antoni, S., Spatuzza, M., Bonaccorso, C. M., Musumeci, S. A., Ciranna, L., Nicoletti, F., Huber, K. M., & Catania, M. V. (2014). Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism. Neuroscience & Biobehavioral Reviews. https://doi.org/10.1016/j.neubiorev.2014.02.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.